Agios Pharmaceuticals Inc (AGIO)
31.68
+0.01
(+0.03%)
USD |
NASDAQ |
Apr 25, 16:00
31.68
0.00 (0.00%)
After-Hours: 20:00
Agios Pharmaceuticals Revenue (TTM): 26.82M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 26.82M |
September 30, 2023 | 24.03M |
June 30, 2023 | 20.15M |
March 31, 2023 | 19.02M |
December 31, 2022 | 14.24M |
September 30, 2022 | |
June 30, 2022 | |
March 31, 2022 | |
December 31, 2021 | |
September 30, 2021 | |
June 30, 2021 | |
March 31, 2021 | |
December 31, 2020 | |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | 0.00 |
September 30, 2019 | 112.48M |
June 30, 2019 | 101.66M |
March 31, 2019 | 115.85M |
December 31, 2018 | 94.39M |
September 30, 2018 | 74.17M |
June 30, 2018 | 70.33M |
Date | Value |
---|---|
March 31, 2018 | 41.26M |
December 31, 2017 | 43.01M |
September 30, 2017 | 55.86M |
June 30, 2017 | 53.49M |
March 31, 2017 | 49.12M |
December 31, 2016 | 69.89M |
September 30, 2016 | 53.46M |
June 30, 2016 | 49.96M |
March 31, 2016 | 56.20M |
December 31, 2015 | 59.12M |
September 30, 2015 | 67.54M |
June 30, 2015 | 95.96M |
March 31, 2015 | 91.15M |
December 31, 2014 | 65.36M |
September 30, 2014 | 57.47M |
June 30, 2014 | 29.83M |
March 31, 2014 | 27.69M |
December 31, 2013 | 25.55M |
September 30, 2013 | 25.09M |
June 30, 2013 | 25.09M |
March 31, 2013 | 25.11M |
December 31, 2012 | 25.11M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
--
Minimum
Dec 2019
112.48M
Maximum
Sep 2019
39.80M
Average
22.09M
Median
Revenue (TTM) Benchmarks
Alnylam Pharmaceuticals Inc | 1.828B |
Blueprint Medicines Corp | 249.38M |
Corcept Therapeutics Inc | 482.38M |
Ionis Pharmaceuticals Inc | 787.65M |
Madrigal Pharmaceuticals Inc | -- |